157 related articles for article (PubMed ID: 37575749)
1. Malignant Perivascular Epithelioid Cell Tumor of the Uterus.
Dhanesar GK; Rengarajan H; Chakraborty B
Cureus; 2023 Jul; 15(7):e41685. PubMed ID: 37575749
[TBL] [Abstract][Full Text] [Related]
2. A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report.
Meredith L; Chao T; Nevler A; Basu Mallick A; Singla RK; McCue PA; Bowne WB; Jiang W
Diagn Pathol; 2023 Apr; 18(1):45. PubMed ID: 37041531
[TBL] [Abstract][Full Text] [Related]
3. Pneumothorax caused by cystic and nodular lung metastases from a malignant uterine perivascular epithelioid cell tumor (PEComa).
Okamoto S; Komura M; Terao Y; Kurisaki-Arakawa A; Hayashi T; Saito T; Togo S; Shiokawa A; Mitani K; Kobayashi E; Kumasaka T; Takahashi K; Seyama K
Respir Med Case Rep; 2017; 22():77-82. PubMed ID: 28706850
[TBL] [Abstract][Full Text] [Related]
4. Perivascular epithelioid cell tumor ('PEComa') of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors.
Vang R; Kempson RL
Am J Surg Pathol; 2002 Jan; 26(1):1-13. PubMed ID: 11756764
[TBL] [Abstract][Full Text] [Related]
5. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.
Wagner AJ; Malinowska-Kolodziej I; Morgan JA; Qin W; Fletcher CD; Vena N; Ligon AH; Antonescu CR; Ramaiya NH; Demetri GD; Kwiatkowski DJ; Maki RG
J Clin Oncol; 2010 Feb; 28(5):835-40. PubMed ID: 20048174
[TBL] [Abstract][Full Text] [Related]
6. [Uterine malignant perivascular epithelioid cell tumor (PEComa): Two case reports].
El Gani-Mesrar M; Bonneau C; Michenet P; Gourvennec JB; Tabareau-Delalande F
Ann Pathol; 2021 Feb; 41(1):118-122. PubMed ID: 32646778
[TBL] [Abstract][Full Text] [Related]
7. Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma.
Pan CC; Chung MY; Ng KF; Liu CY; Wang JS; Chai CY; Huang SH; Chen PC; Ho DM
J Pathol; 2008 Feb; 214(3):387-93. PubMed ID: 18085521
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature.
Starbuck KD; Drake RD; Budd GT; Rose PG
Anticancer Res; 2016 Nov; 36(11):6161-6164. PubMed ID: 27793946
[TBL] [Abstract][Full Text] [Related]
9. TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review.
Purwar R; Soni K; Shukla M; Verma A; Kumar T; Pandey M
World J Surg Oncol; 2022 Mar; 20(1):62. PubMed ID: 35232443
[TBL] [Abstract][Full Text] [Related]
10. Malignant perivascular epithelioid cell tumor (PEComa) of the uterus.
Cao B; Huang Y
BMC Womens Health; 2022 Dec; 22(1):523. PubMed ID: 36522714
[TBL] [Abstract][Full Text] [Related]
11. VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature.
Liapi A; Mathevet P; Herrera FG; Hastir D; Sarivalasis A
Front Oncol; 2021; 11():641376. PubMed ID: 33842348
[TBL] [Abstract][Full Text] [Related]
12. Malignant perivascular epithelioid cell tumor (PEComa) of the uterus with late renal and pulmonary metastases: a case report with review of the literature.
Armah HB; Parwani AV
Diagn Pathol; 2007 Dec; 2():45. PubMed ID: 18053181
[TBL] [Abstract][Full Text] [Related]
13. PEComa: morphology and genetics of a complex tumor family.
Thway K; Fisher C
Ann Diagn Pathol; 2015 Oct; 19(5):359-68. PubMed ID: 26144278
[TBL] [Abstract][Full Text] [Related]
14. TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms.
Schmiester M; Dolnik A; Kornak U; Pfitzner B; Hummel M; Treue D; Hartmann A; Agaimy A; Weyerer V; Lekaj A; Brakemeier S; Peters R; Öllinger R; Märdian S; Bullinger L; Striefler JK; Flörcken A
J Pathol Clin Res; 2021 Jan; 7(1):3-9. PubMed ID: 33180365
[TBL] [Abstract][Full Text] [Related]
15. Rapid and Durable Response With Nab-Sirolimus After Everolimus Failure in a Patient With Perivascular Epithelioid Cell Tumors (PEComas) of the Uterus.
Kopparthy P; Murphy M
Cureus; 2021 May; 13(5):e14951. PubMed ID: 34123648
[TBL] [Abstract][Full Text] [Related]
16. Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates.
Dickson MA; Schwartz GK; Antonescu CR; Kwiatkowski DJ; Malinowska IA
Int J Cancer; 2013 Apr; 132(7):1711-7. PubMed ID: 22927055
[TBL] [Abstract][Full Text] [Related]
17. Malignant perivascular epithelioid cell tumor (PEComa) arising in the broad ligament.
Fink D; Marsden DE; Edwards L; Camaris C; Hacker NF
Int J Gynecol Cancer; 2004; 14(5):1036-9. PubMed ID: 15361222
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous perivascular epithelioid cell tumor (PEComa): case report and world literature review of clinical and molecular characteristics.
Cohen PR; Kato SM; Erickson CP; Calame A; Kurzrock R
Dermatol Online J; 2022 Jan; 28(1):. PubMed ID: 35499412
[TBL] [Abstract][Full Text] [Related]
19. TFE3 Gene Rearrangement in Perivascular Epithelioid Cell Neoplasm (PEComa) of the Genitourinary Tract.
Vannucchi M; Minervini A; Salvi M; Montironi R; Raspollini MR
Clin Genitourin Cancer; 2020 Dec; 18(6):e692-e697. PubMed ID: 32576448
[TBL] [Abstract][Full Text] [Related]
20. [Perivascular epithelioid cell tumor, not otherwise specified: a clinicopathologic and immunohistochemical analysis of 31 cases].
Cai JN; Shi M; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):240-5. PubMed ID: 21615997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
